Pancreatic Cancer /
| Corporate Author: | |
|---|---|
| Other Authors: | , , , |
| Format: | eBook |
| Language: | English |
| Published: |
New York, NY :
Springer New York : Imprint: Springer,
2010.
|
| Edition: | 1st ed. 2010. |
| Subjects: |
Table of Contents:
- Epidemiology: world overview, risk factors, prospects for prevention
- Development and structure of pancreas
- Pathologic classification and biological behaviour of pancreatic neoplasia
- Developmental molecular biology of the pancreas
- Molecular pathology of precursor lesions of pancreatic cancer, pancreatic intraepithelial neoplasia (PanIN), intraductal papillary mucinous neoplasm (IPMN), and mucinous cystic neoplasm (MCN)
- Epigenetics: its fundamentals and applications to a revised comprehensive progression model for pancreatic cancer
- Molecular pathology of pancreatic neuroendocrine tumours MEN-1: gastrinomas, insulinoma, Non-Functioning Tumours, VIPoma, glucagonoma, Von Hippel-Lindau, Neurofibromatosis
- Sporadic neuroendocrine pancreatic tumours
- Molecular pathology of non-pancreatic cancer lesions: Ampullary cancer, intra-pancreatic bile duct cancer, and duodenal cancer
- Miscellaneous non-pancreatic non-endocrine tumours
- Novel molecular relationships between chronic pancreatitis and cancer
- Pancreatic cancer stem cells
- Cell cycle control: signalling pathways in pancreatic pathogenesis
- Apoptosis: signalling pathways in pancreatic pathogenesis
- EGFR: signalling pathways in pancreatic pathogenesis Pl3, Akt, lKK, Ras, Raf, MAPKK, ERK
- Hedgehog: signalling pathways in pancreatic pathogenesis
- Smad4/TGF-ß pathway: signalling pathways in pancreatic pathogenesis
- Notch signalling in pancreatic morphogenesis and pancreatic cancer
- Molecular characterization of pancreatic cell lines
- Mouse models of exocrine pancreatic cancer
- Principles and applications of microarray gene expression in pancreatic cancer
- Principles and applications of proteomics in pancreatic cancer
- Tumour-stromal interaction: invasion and metastases
- Genetic susceptibility, high risk groups, chronic and hereditary pancreatitis, familial pancreatic cancer syndromes
- Inherited endocrine pancreatic tumors associated with Multiple Endocrine Neoplasia Type 1 Von-Hippel-Lindau Syndrome, and Neurofibromatosis Type 1
- Clinical decision making in pancreatic cancer
- Paraneoplastic syndromes
- Diagnostic and therapeutic response markers
- CT and fusion PET-CT Diagnosis, staging, and follow-up
- MRI and MRCP: diagnosis and staging of pancreatic cancer
- EUS Diagnosis and staging
- Laparoscopy and laparoscopic ultrasound: diagnosis and staging
- Overview of palliative management for pancreatic cancer
- Endoscopy
- Interventional radiology
- Role of palliative surgery in advanced pancreatic cancer
- Chemotherapy for advanced pancreatic cancer
- Developments in chemoradiation in advanced pancreatic cancer
- Surgical resection for pancreatic cancer
- Role of venous resection in pancreatic cancer surgery
- Pathological reporting and staging following resection
- Japanese Pancreas Society staging for pancreatic cancer
- Adjuvant chemotherapy in pancreatic cancer
- Case for adjuvant chemoradiation therapy for pancreatic cancer
- Case for neoadjuvant treatment in pancreatic cancer
- Borderline resectable disease
- Management of cystic neoplasms serous cystic neoplasms mucinous, cystic neoplasms, intraductal paillary mucinous neoplasms
- Laparoscopic surgery for pancreatic neoplasm
- Modern Japanese approach to pancreas cancer
- Development of novel biomarkers
- Inherited genetics of pancreatic cancer and secondary screening
- Gene therapy for pancreatic cancer
- Vaccine therapy and immunotherapy
- Emerging targets in pancreatic cancer.-.